Genmab — December 2014
-
spænende TAC og AXL grafer. de er ved at kunne noget indenfor ADC
-
hørte jeg ikke. til hvad ?
-
det er jo logisk at de løbende over de næste mange år løbende vil udvide pipeline med nye produkter.
-
nok ikke en af deres enge produkter.
-
men Duobody Jannsen. Humax-TAC, Lundbeck kan jo stadig give IND
-
enig sukker
-
de har IND filings på deres 2015 to do liste
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind